동물용 안과 의료 시장 규모 : 제품·서비스별, 동물 유형별, 적응증별, 최종 용도별 및 예측(2024-2032년)

Global Veterinary Eye Care Market will register 3.5% CAGR between 2024 and 2032, driven by the high incidence of eye conditions in pets, in line with advancements in veterinary ophthalmology and the introduction of specialized eye care products. With pets facing common ailments like cataracts, glaucoma, and infections, the demand for effective treatments is significant. Furthermore, the development of modern diagnostic tools and innovative treatments enhances the quality of care. This creates a promising landscape for the expansion of the veterinary eye care industry, catering to the increasing needs of pet owners seeking optimal eye health for their companions.

For instance, in January 2024, ENTOD Pharmaceuticals introduced 'FUR,' a division offering eye and ear care medicines for pets. FUR provides a diverse range of veterinary solutions, including lubricating drops, anti-glaucoma medications, anti-allergies, antibiotics, and combinations. It reflects the growing awareness and demand for pet health products, suggesting an increasing focus on addressing specific ocular and aural conditions in pets. This development could contribute to the market growth by offering innovative treatments and enhancing the availability of veterinary eye and ear care options on a broader scale.

The veterinary eye care market is fragmented based on products and services, animal type, indication, end-use, and region.

The feline segment will witness a notable expansion over 2024-2032, fueled by a growing emphasis on feline health, particularly their delicate ocular needs. Cat owners worldwide are increasingly prioritizing comprehensive eye care, from preventive measures to advanced treatments. With cats being popular pets globally, this segment's prominence could grow steadily. As the bond between owners and their feline companions strengthens, so does the recognition of the importance of maintaining optimal eye health, making the feline segment a key driver in the veterinary eye care industry.

The diagnostic laboratories segment will exhibit a healthy growth rate through 2032, propelled by the increasing demand for accurate and timely diagnoses of various eye conditions in pets. These specialized laboratories offer advanced diagnostic tools and expertise, aiding veterinarians in pinpointing ocular diseases with precision. As pet owners become more proactive about their pets' health, the reliance on diagnostic laboratories for thorough eye examinations grows. With their crucial role in identifying and managing eye issues, the diagnostic laboratories segment will emerge as a pivotal component of the pet care industry's growth.

Asia Pacific veterinary eye care market size will experience a substantial CAGR from 2024 to 2032. Rapid urbanization, increasing pet adoption rates, and a growing awareness of animal health drive this trend. Moreover, the region's rising disposable incomes allow for greater spending on pet healthcare. Technological advancements in veterinary ophthalmology also play a role in enhancing diagnosis and treatment options. With an increasing number of pet owners seeking high-quality eye treatments, the Asia Pacific region will stand as a remarkable contributor to the global veterinary eye care industry growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast parameters
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of eye disorders in pets
    • 3.2.1.2 Increasing veterinary healthcare expenditure
    • 3.2.1.3 Increasing pet ownership globally
    • 3.2.1.4 Advancements in veterinary ophthalmology
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of treatment
    • 3.2.2.2 Lack of insurance coverage
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
  • 3.5.1 Supplier power
  • 3.5.2 Buyer power
  • 3.5.3 Threat of new entrants
  • 3.5.4 Threat of substitutes
  • 3.5.5 Industry rivalry
• 3.6 PESTEL analysis
• 3.7 Pricing analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product & Services, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Veterinary care products
  • 5.2.1 Diagnosis
    • 5.2.1.1 Tonometer
    • 5.2.1.2 Ophthalmic test kits
    • 5.2.1.3 Electroretinogram (ERG)
    • 5.2.1.4 Fundus camera
    • 5.2.1.5 Ophthalmoscope
    • 5.2.1.6 Pachymeter
    • 5.2.1.7 Other diagnostic products
  • 5.2.2 Treatment
    • 5.2.2.1 Drugs
      • 5.2.2.1.1 Drug type
      • 5.2.2.1.1.1 Antibiotics
      • 5.2.2.1.1.2 NSAIDs
      • 5.2.2.1.1.3 Corticosteroids
      • 5.2.2.1.1.4 Other drugs
      • 5.2.2.1.2 By route of administration
      • 5.2.2.1.2.1 Oral
      • 5.2.2.1.2.2 Topical
      • 5.2.2.1.2.3 Injectable
      • 5.2.2.1.3 By distribution channel
      • 5.2.2.1.3.1 Veterinary hospitals pharmacies
      • 5.2.2.1.3.2 Retail drug stores
      • 5.2.2.1.3.3 Pet specialty stores
      • 5.2.2.1.3.4 E-commerce
    • 5.2.2.2 Lenses
      • 5.2.2.2.1 Bandage lenses
      • 5.2.2.2.2 Intraocular lenses
    • 5.2.2.3 Laser devices
• 5.3 Veterinary care services

Chapter 6 Market Estimates and Forecast, By Animal Type, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Canine
• 6.3 Feline
• 6.4 Equine
• 6.5 Bovine
• 6.6 Other animal type

Chapter 7 Market Estimates and Forecast, By Indication, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Eyelid abnormalities
• 7.3 Cataract
• 7.4 Glaucoma
• 7.5 Retinal disorders
• 7.6 Uveitis
• 7.7 Conjunctivitis
• 7.8 Corneal ulcers
• 7.9 Other indications

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Veterinary hospitals
• 8.3 Diagnostic laboratories
• 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 An-Vision GmbH
• 10.2 Bausch & Lomb Inc.
• 10.3 Boehringer Ingelheim International GmbH
• 10.4 Ceva Sante Animale
• 10.5 Dechra Pharmaceuticals PLC
• 10.6 IRIDEX Corporation
• 10.7 I-Med Animal Health
• 10.8 LKC Technologies, Inc.
• 10.9 Neuronix Ltd.
• 10.10 OptoMed
• 10.11 Reichert, Inc.
• 10.12 Zoetis Services LLC